Tags

Type your tag names separated by a space and hit enter

Dihydromyricetin incorporated active films based on konjac glucomannan and gellan gum.
Int J Biol Macromol. 2021 Jun 01; 180:385-391.IJ

Abstract

Active composite films were developed by incorporating different concentration of dihydromyricetin (DMY) into konjac glucomannan (KGM)/gellan gum (GG) matrix. Physicochemical, mechanical, released behaviour, antioxidant and antimicrobial properties of composite films were investigated. The results from the Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) indicated that DMY which well-dispersed in the KGM/GG matrix interacted with matrix through hydrogen bonds. The obtained films presented predominant thermostability, good water resistance property, excellent ultraviolet light barrier ability and sustained controlled release behaviour. In particular, the incorporation of DMY remarkably enhanced the antioxidant and antimicrobial activities of the films. Overall, the fabricated KGM/GG-DMY composite films have a promising application in the fields of food packaging.

Authors+Show Affiliations

College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China.School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, China.College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China.College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China. Electronic address: pang3721941@163.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33652043

Citation

Xie, Wanzhen, et al. "Dihydromyricetin Incorporated Active Films Based On Konjac Glucomannan and Gellan Gum." International Journal of Biological Macromolecules, vol. 180, 2021, pp. 385-391.
Xie W, Du Y, Yuan S, et al. Dihydromyricetin incorporated active films based on konjac glucomannan and gellan gum. Int J Biol Macromol. 2021;180:385-391.
Xie, W., Du, Y., Yuan, S., & Pang, J. (2021). Dihydromyricetin incorporated active films based on konjac glucomannan and gellan gum. International Journal of Biological Macromolecules, 180, 385-391. https://doi.org/10.1016/j.ijbiomac.2021.02.185
Xie W, et al. Dihydromyricetin Incorporated Active Films Based On Konjac Glucomannan and Gellan Gum. Int J Biol Macromol. 2021 Jun 1;180:385-391. PubMed PMID: 33652043.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dihydromyricetin incorporated active films based on konjac glucomannan and gellan gum. AU - Xie,Wanzhen, AU - Du,Yu, AU - Yuan,Shuyi, AU - Pang,Jie, Y1 - 2021/02/27/ PY - 2020/10/26/received PY - 2021/02/24/revised PY - 2021/02/25/accepted PY - 2021/3/3/pubmed PY - 2021/7/27/medline PY - 2021/3/2/entrez KW - Active packaging KW - Gellan gum KW - Konjac glucomannan SP - 385 EP - 391 JF - International journal of biological macromolecules JO - Int J Biol Macromol VL - 180 N2 - Active composite films were developed by incorporating different concentration of dihydromyricetin (DMY) into konjac glucomannan (KGM)/gellan gum (GG) matrix. Physicochemical, mechanical, released behaviour, antioxidant and antimicrobial properties of composite films were investigated. The results from the Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) indicated that DMY which well-dispersed in the KGM/GG matrix interacted with matrix through hydrogen bonds. The obtained films presented predominant thermostability, good water resistance property, excellent ultraviolet light barrier ability and sustained controlled release behaviour. In particular, the incorporation of DMY remarkably enhanced the antioxidant and antimicrobial activities of the films. Overall, the fabricated KGM/GG-DMY composite films have a promising application in the fields of food packaging. SN - 1879-0003 UR - https://www.unboundmedicine.com/medline/citation/33652043/Dihydromyricetin_incorporated_active_films_based_on_konjac_glucomannan_and_gellan_gum_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0141-8130(21)00482-7 DB - PRIME DP - Unbound Medicine ER -